PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: IGF-1 LR3, Long R3 IGF-1, Receptor Grade IGF-1 LR3
IGF-1 LR3 (Long R3 IGF-1) is an engineered, long-acting analog of insulin-like growth factor 1 studied for sustained anabolic and tissue-growth signaling. Its modifications give it a far longer half-life than native IGF-1.
Sign in to rate this peptide.
IGF-1 LR3 carries an arginine substitution at position 3 plus a 13-amino-acid N-terminal extension, which sharply reduce its affinity for IGF-binding proteins and extend its circulating half-life. With prolonged availability of free peptide, it strongly and persistently activates the IGF-1 receptor (IGF-1R) tyrosine kinase, driving PI3K/Akt/mTOR and Ras/MAPK signaling that promotes protein synthesis, cell proliferation, and inhibition of apoptosis. This produces systemic, sustained anabolic effects in research models.